This was an analytical, cross-sectional study conducted from January 2020 to March 30, 2021, in the Endocrinology-Diabetology Department of Yopougon University Hospital in Abidjan, specifically within its outpatient consultation unit.

The study population consisted of all type 2 diabetic patients followed at Yopougon University Hospital during the study period.

Inclusion criteria:Patients with a diagnosis of type 2 diabetes established according to WHO criteria, followed at Yopougon University Hospital for at least 6 months.Type 2 diabetic patients followed at Yopougon University Hospital who had undergone the HbA1c test at least twice.Non-inclusion criteria:Patients with a type of diabetes other than type 2;Patients with confirmed cardiovascular disease or a comorbidity for whom the 7% target is difficult to achieve because of the risk of hypoglycemia;Type 2 diabetic patients who became pregnant during follow-up.

Poor glycemic control was defined as an HbA1c level ≥ 7%, in accordance with the recommendations of the American Diabetes Association (ADA) and the African Society for Diabetology and Endocrinology (SFADE).

The variables studied included:Sociodemographic factors (age, sex, education level, occupation);Clinical factors (diabetes duration, body mass index, treatment type, comorbidity).

We initially identified the records of all patients who had consulted Yopougon University Hospital for type 2 diabetes. We then listed the patients with poor glycemic control who met our inclusion criteria and administered pre-established questionnaires to them.

The collected data were entered and analyzed using EPI-INFO version 7 software. Tables, graphs, and figures were produced using Microsoft Office 2010 Excel and Word. Univariate analysis was performed using the chi-square independence test. The difference was considered statistically significant when p < 0.05.

In the study population, 198 patients (66.0%) had been living with diabetes for more than 5 years (See Table 2). Obesity (BMI ≥ 30 kg/m²) affected 128 patients (46.0%); 168 patients (58.0%) also had arterial hypertension; and the majority of patients were on dual oral therapy, 126 (42.0%).

During our study period, 568 diabetic patients consulted at Yopougon University Hospital, of whom we included 300. Of these 300 patients, 196 had poor glycemic control (HbA1c ≥ 7%), giving a prevalence of 65.3%. This prevalence is comparable to that reported by Amoah et al. in Ghana (63.2%) [11] and by Lokrou et al. in Côte d’Ivoire (61%) [12]. These figures highlight the need to optimize diabetes treatment in developing countries in order to minimize its complications. Our data contrast with those of Cai in China (31.5%) [13].

The mean HbA1c value was 8.4%, a concerning figure given the associated complications. Indeed, each 1% increase in HbA1c is associated with an increased risk of complications: a 37% increase in the risk of macrovascular complications and a 14% increase in the risk of myocardial infarction, according to UKPDS data [14].

The mean age was 52.4 ± 11.8 years, with the 40 - 60 year age group predominating. The same finding was reported by Barankanira in Burundi [9]. The high proportion of relatively young patients in our study is concerning and raises questions about the challenges to be addressed in preventing cardiovascular complications and the risk of premature death.

Unlike the findings of Al-Nuaim et al. in Saudi Arabia [15] and Traoré et al. in Burkina Faso [16], who identified sex as a factor associated with poor glycemic control, sex was not a risk factor for poor glycemic control in our study. The same finding was reported by Ben Abdelaziz et al. in Tunis [17].

Financial dependence and lack of health insurance coverage (aOR = 2.18) negatively affect glycemic balance (Table 4). These results confirm those reported in the literature, which show that low socioeconomic status affects access to healthcare services and quality of care [18]-[20].

Table 4. Independent factors associated with poor glycemic control—Multivariate analysis (n = 300).

Regarding educational status, a low education level (aOR = 1.96) was associated with poor glycemic control in our study. Our data corroborate many other studies that have found an association between low education level and poor glycemic control [21][22]. This result may be explained by the difficulty these patients have in understanding therapeutic education, leading them to resort more often to traditional treatment for managing their diabetes.

In the literature, opinions on the relationship between diabetes duration and glycemic control are divided. Some authors found that diabetes duration was not a risk factor for poor glycemic control [23]. Others reported that a duration greater than 10 years was associated with poor glycemic control [24], while still others found the opposite [25][26]. For Valle et al., newly diagnosed patients (<3 years) had good glycemic control [27]. In our study, a diabetes duration of more than 5 years (aOR = 2.87) was associated with poor control, with a statistically significant difference. This difference may be explained by the progressive deterioration of pancreatic beta-cell function in the islets of Langerhans over time, which makes glycemic balance increasingly difficult to achieve.

Regarding cardiovascular risk factors, obesity (BMI ≥ 30 kg/m²) was a risk factor for poor glycemic control in our study (aOR = 2.43). This finding was also reported by Bruno G. and Blaum CS et al. [28][29]. Indeed, obesity causes insulin resistance, and the high prevalence of obese patients in our study worsened the risk of poor glycemic control. Factors such as arterial hypertension and dyslipidemia were not risk factors for poor glycemic control in our study.

Among the behavioral factors associated with poor glycemic control, we identified therapeutic non-adherence, non-adherence to dietary recommendations, and reliance on traditional therapy as strongly associated factors.

Non-adherence to treatment is an obstacle to good glycemic balance (aOR = 4.12). This result is consistent with the meta-analysis by Krass et al. of 28 studies, which concluded that non-adherence multiplies the risk of poor glycemic control by 3 to 5 times [30]. In our study, the reasons cited by patients for non-adherence to treatment included financial difficulties in purchasing medications and attending consultations, mistaken beliefs about chronic illness, and reliance on traditional therapy.

The second behavioral factor associated with poor glycemic control was non-adherence to dietary recommendations (aOR = 3.58). Dietary recommendations are difficult to follow.

This observation highlights the need to adapt nutritional advice to local dietary habits, as recommended by several authors [31][32].

The third factor identified in our study was reliance on traditional therapy (aOR = 3.21). Numerous Sahelian and West African studies have reported prevalences ranging from 30% to 55%. This phenomenon is often responsible for interruptions in conventional treatment [33].